← All Protocols
Protocol 03 · Peptide Therapy
Peptide Therapy.
Precision Built Into the Protocol.
Peptide protocols selected for recovery, body composition, metabolic health, hormone optimization, cognition, immune signaling, and longevity research. Every option is evaluated by indication, evidence, regulatory status, sourcing, and patient-specific risk before it enters a BIOGENEX plan.
Framework
25+ Compounds Evaluated
Targets
Recovery · Metabolic · Longevity
Integration
Hormone · Weight · Performance
The Signal
What a Peptide
Actually Is.
A peptide is a short chain of amino acids that can act as a highly specific biological signal. Your body already uses peptide signals to regulate appetite, glucose handling, growth-hormone activity, immune response, tissue remodeling, and cellular communication. That specificity is why peptide therapy can become a powerful component of precision medicine.
The category is broad. Some peptide medicines have FDA-approved indications and substantial human data. Others are prescribed off label, prepared by compounding pharmacies when legally appropriate, or remain investigational with evidence concentrated in mechanistic, animal, or early human studies. BIOGENEX does not collapse those categories into one claim. We identify the target, grade the evidence, confirm lawful availability, and build only what fits the patient.
Signal 01
Recovery & Tissue Support
BPC-157 and thymosin beta-4 derivatives are studied for repair signaling, angiogenesis, cell migration, and connective-tissue recovery. The mechanistic and preclinical signal is compelling; human outcome data remain limited.
Signal 02
Body Composition & GH Axis
Tesamorelin and other growth-hormone-axis peptides can influence visceral fat, body composition, recovery, and anabolic signaling. Selection depends on indication, contraindications, and monitoring.
Signal 03
Hormone Protocol Integration
Peptides may complement TRT or HRT when recovery, lean-mass retention, sleep, body composition, or metabolic response remains a defined constraint.
Signal 04
Metabolic & Weight Protocols
Approved incretin therapies and selected peptide adjuncts can be integrated with nutrition, resistance training, body-composition tracking, and hormone care rather than deployed as isolated weight-loss products.
Signal 05
Cognitive & Immune Research
Semax, Selank, and thymosin alpha-1 are discussed in neurocognitive, stress-response, and immune research. Evidence and U.S. regulatory status differ materially by compound.
Signal 06
Longevity Signaling
Epithalon, Pinealon, mitochondrial peptides, and related compounds are studied in aging biology and cellular signaling. They remain an emerging field, not a universal longevity guarantee.
Where Standard Care Fails
Why Most Clinicians
Still Ignore Them.
Signals, Not Standalone Products.
Peptide therapy is most powerful when it solves a defined constraint inside a larger plan. A recovery peptide without training architecture is incomplete. A metabolic peptide without nutrition, resistance training, and lean-mass surveillance is incomplete. A growth-hormone-axis intervention without glucose and IGF-1 monitoring is incomplete.
BIOGENEX integrates peptide protocols with hormone optimization, metabolic care, body-composition strategy, sleep, training, and biomarker surveillance. The compound is not the strategy. The complete protocol is the strategy.
25+
Compounds evaluated within the framework
3
Evidence tiers: established, emerging, investigational
1:1
Clinician-selected and monitored
65+
Biomarkers available to guide the protocol
The Formulary
Select Compounds.
A sample of the clinician-selected peptides in the BIOGENEX formulary, and access to many more. Every protocol is prescribed and dosed to your biology, never sold as a fixed menu.
Recovery · Emerging Evidence
BPC-157 / TB4 (TB-500)
Studied for repair signaling, vascular response, cell migration, tendon, muscle, and connective-tissue recovery. Their biological rationale and preclinical literature are substantial, while controlled human outcome data remain limited.
Visceral Fat · Established Indication
Tesamorelin
An FDA-approved growth-hormone-releasing factor analog for reducing excess abdominal fat in adults with HIV and lipodystrophy. Other proposed uses require separate clinical and regulatory analysis.
Growth Signaling · Advanced
IGF-1 LR3 / GH-Axis Peptides
Compounds affecting growth and IGF-1 signaling are evaluated for body composition, recovery, and performance objectives with close attention to glucose regulation, IGF-1 exposure, contraindications, and lawful availability.
Neurocognitive · Stress Response
Semax / Selank
Peptides studied internationally for neurocognitive and stress-response signaling. The evidence base includes human research, but neither compound has an FDA-approved indication in the United States.
Immune Signaling
Thymosin Alpha-1
TA1 has an international clinical history and human research across immune and infectious-disease contexts. U.S. indication, compounding status, and patient fit must be assessed separately.
Mitochondrial · Metabolic Research
MOTS-c
A mitochondrial-derived peptide studied in metabolic signaling, exercise physiology, and aging biology. Human therapeutic evidence remains early and it is not FDA approved.
Longevity · Bioregulator Research
Epithalon / Pinealon
Investigated in aging, circadian, neuroendocrine, and cellular-regulation research. These compounds remain investigational in the United States and are not presented as proven lifespan-extension therapies.
The BIOGENEX Framework
Evidence Tiered. Protocol Integrated.
BIOGENEX evaluates more than twenty-five peptide and peptide-adjacent compounds across recovery, growth, metabolic, cognitive, immune, and longevity targets. Discussion does not guarantee prescription or availability; every decision depends on evidence, lawful sourcing, clinical appropriateness, and informed consent.
The BIOGENEX Protocol
How We
Prescribe Precision.
01
Define the Constraint
We map biomarkers, medications, goals, and the limiting variable: recovery, body composition, metabolic response, sleep, cognition, immune resilience, or longevity strategy.
02
Grade Evidence and Availability
We distinguish approved indications, off-label use, patient-specific compounding, and investigational research. A compelling mechanism never replaces legal availability or informed consent.
03
Integrate, Monitor, Adapt
When appropriate, peptide therapy is integrated with hormone or metabolic care, then monitored through symptoms, body composition, performance metrics, and relevant laboratory data.
Questions, Answered
Peptide Therapy, Answered.
Are all peptide therapies FDA approved?
No. Peptide therapy includes FDA-approved medicines, off-label applications of approved drugs, patient-specific compounded preparations where legally permitted, and investigational compounds. Each category carries a different evidence, quality, and regulatory profile.
Is FDA reconsidering access to certain compounded peptides?
Yes. FDA has initiated reconsideration and scheduled advisory review of certain peptides previously placed in Category 2, with additional reviews expected. A substance under review has not automatically returned to Category 1 or the final 503A bulks list, and review alone does not establish current permission to compound it.
Do peptides have evidence for recovery, metabolic health, and longevity?
Yes, but the strength of evidence is compound-specific. Some peptide medicines have robust randomized human trials and approved indications. Others have early human, mechanistic, or substantial preclinical data that supports further investigation but does not establish the same level of clinical certainty.
Can peptide therapy be added to TRT or HRT?
Yes, when it addresses a defined need such as recovery, body composition, sleep, metabolic response, or lean-mass support and the combination is clinically appropriate. It is integrated into the hormone protocol rather than sold as an unrelated add-on.
Can peptides be part of a weight-loss protocol?
Yes. Approved incretin medicines are peptides, and other peptide strategies may be evaluated as adjuncts within a monitored metabolic plan. BIOGENEX pairs medication decisions with nutrition, resistance training, body-composition surveillance, hormone assessment, and follow-up.
Does a compounded peptide mean it is FDA approved?
No. Compounded drugs are not FDA approved. A licensed pharmacy, prescription, and clinician oversight are important safeguards, but lawful compounding eligibility and evidence must still be evaluated for the specific substance and patient.
Begin Your Protocol
Signal, Not Noise.
Engineer the Response.
Book your $89 consultation. We define your target and prescribe the precise peptide protocol to reach it.
Avon, CT · Telehealth in Eligible States · Response Within 24 Hrs
